A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04481009 |
|
Recruitment Status :
Completed
First Posted : July 22, 2020
Last Update Posted : December 12, 2022
|
Sponsor:
Eucure (Beijing) Biopharma Co., Ltd
Information provided by (Responsible Party):
Eucure (Beijing) Biopharma Co., Ltd
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 16, 2022 |
| Actual Study Completion Date : | May 26, 2022 |